Indication
Chromium deficiency
Chromium deficiency is a rare nutritional and metabolic state characterized by inadequate systemic levels of trivalent chromium, an essential trace element that potentiates insulin action and facilitates carbohydrate, lipid, and protein metabolism. Read more about Chromium deficiency
6 drugs 6 manufacturers
Drugs that treat it
Common Chromium deficiency therapies.
CHROMIUM (chromic chloride)
CHROMIUM (chromic chloride)
CHROMIUM (chromic chloride)
CHROMIC CHLORIDE
CHROMIC CHLORIDE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChromium deficiency is a rare nutritional and metabolic state characterized by inadequate systemic levels of trivalent chromium, an essential trace element that potentiates insulin action and facilitates carbohydrate, lipid, and protein metabolism.
It primarily affects patients receiving prolonged total parenteral nutrition without adequate trace mineral supplementation, as well as individuals with severe malabsorption or extreme metabolic stress.
Clinically, the condition manifests as unexplained insulin resistance, impaired glucose tolerance or severe hyperglycemia, weight loss, and neuromuscular abnormalities such as peripheral neuropathy, ataxia, and metabolic encephalopathy.
- nih.gov
Chromium deficiency is a rare nutritional and metabolic state characterized by inadequate systemic levels of trivalent chromium, an essential trace element that potentiates insulin action and facilitates carbohydrate, lipid, and protein metabolism It primarily affects patients receiving prolonged total parenteral nutrition without adequate trace mineral supplementation, as well as individuals with severe malabsorption or extreme metabolic stress
- nih.gov
Chromium deficiency is a rare nutritional and metabolic state characterized by inadequate systemic levels of trivalent chromium, an essential trace element that potentiates insulin action and facilitates carbohydrate, lipid, and protein metabolism
- merckmanuals.com
It primarily affects patients receiving prolonged total parenteral nutrition without adequate trace mineral supplementation, as well as individuals with severe malabsorption or extreme metabolic stress Clinically, the condition manifests as unexplained insulin resistance, impaired glucose tolerance or severe hyperglycemia, weight loss, and neuromuscular abnormalities such as peripheral neuropathy, ataxia, and metabolic encephalopathy
- nih.gov
It primarily affects patients receiving prolonged total parenteral nutrition without adequate trace mineral supplementation, as well as individuals with severe malabsorption or extreme metabolic stress Clinically, the condition manifests as unexplained insulin resistance, impaired glucose tolerance or severe hyperglycemia, weight loss, and neuromuscular abnormalities such as peripheral neuropathy, ataxia, and metabolic encephalopathy
- nih.gov
Clinically, the condition manifests as unexplained insulin resistance, impaired glucose tolerance or severe hyperglycemia, weight loss, and neuromuscular abnormalities such as peripheral neuropathy, ataxia, and metabolic encephalopathy
Personalize your experience
Follow Chromium deficiency and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.